Skip to main content
. 2021 Jun 28;12:688073. doi: 10.3389/fphar.2021.688073

FIGURE 3.

FIGURE 3

Treatment with RBPP-P for 4 weeks improved hyperglycaemia and daily indicates in ALX mice (n = 10). Fasting blood glucose (A) and blood glucose reduction (B) were measured. (C) Body weight (D) Food intake. (E) Urine volume (F) Water intake (G) Serum ketone bodies. All data are expressed as mean ± s. d. # p < 0.05, ## p < 0.01, vs. C57BL/6J mice; *p < 0.05, **p < 0.01, vs. ALX mice.